This clinical trial evaluates increasing access to definitive treatment by removing transportation barriers effects underserved patients with prostate cancer. Rideshares are a type of transportation service where a person uses a smartphone application to request a ride from a nearby driver. Researchers want to find out if providing rideshare services reduces missed appointments and travel burdens, and improves the quality of life and enhance outcomes and overall health and wellness throughout underserved patients with prostate cancer.
Additional locations may be listed on ClinicalTrials.gov for NCT06034431.
Locations matching your search criteria
United States
Massachusetts
Boston
Brigham and Women's HospitalStatus: Active
Contact: Quoc-Dien Trinh
Phone: 617-525-7350
Brigham and Women's Faulkner HospitalStatus: Active
Contact: Quoc-Dien Trinh
Phone: 617-525-7350
PRIMARY OBJECTIVES:
I. Estimate the impact of travel burden on timely receipt of definitive prostate cancer (PCa) treatment and treatment type using geospatially modeled travel time from residence to facility where treatment was received.
II. Pilot a trial by offering ridesharing services for Black men seeking definitive PCa treatment in Greater Boston to reduce missed appointments.
III. Conduct multilevel semi-structured interviews to identify barriers to and facilitators of the RE- AIM of ridesharing services through our Prostate Cancer Outreach Clinic (PCOC).
OUTLINE:
AIM 2: Patients receive Uber and/or Lyft rideshares to and from scheduled appointments.
AIM 3: Participants complete semi-structured interview on study.
Trial PhaseNo phase specified
Trial Typehealth services research
Lead OrganizationDana-Farber Harvard Cancer Center
Principal InvestigatorQuoc-Dien Trinh
